PCM
RARX
Prelude Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-11,900
| Closed | -$571K | – | 1869 |
|
|
2020
Q1 | $571K | Sell |
11,900
-19,359
| -62% | -$929K | 0.04% | 161 |
|
|
2019
Q4 | $1.47M | Buy |
+31,259
| New | +$1.47M | 0.06% | 115 |
|
|
2018
Q4 | – | Sell |
-19,246
| Closed | -$348K | – | 1899 |
|
|
2018
Q3 | $348K | Buy |
+19,246
| New | +$348K | 0.02% | 418 |
|